Close
Novotech
Jabsco PureFlo 21 Single Use

Gilead Sciences to Present at the Bank of America Merrill Lynch Healthcare Conference

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

AbbVie to Invest $1.4B in North Carolina Manufacturing Plant

AbbVie has outlined plans to build a major new...

Where to Find Packaging Equipment That Meets Pharmaceutical Standards

In pharmaceutical manufacturing, you operate in an environment where...

Where to Find Leading Certification Programs for Regulatory Compliance

When you decide to buy regulatory compliance certification online,...
- Advertisement -

Gilead Sciences Inc announced that its corporate presentation will be webcast from the Bank of America Merrill Lynch Healthcare Conference in Las Vegas.

Paul R. Carter, Gilead’s Executive Vice President, Commercial Operations, will provide an overview of the company at the conference on Tuesday, May 10 at 9:20 a.m. Pacific Time.

The live webcast can be accessed at the company’s Investors page at www.gilead.com/investors. Please connect to the company’s website at least 15 minutes prior to the start of the presentation to ensure adequate time for any software download that may be required to listen to the webcast. The replay will be available for 14 days following the presentation.

About Gilead
Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company’s mission is to advance the care of patients suffering from life-threatening diseases. Gilead has operations in more than 30 countries worldwide, with headquarters in Foster City, California.

For more information on Gilead Sciences, please visit the company’s website at www.gilead.com.

Source: Gilead Sciences, Inc.
Sung Lee, 650-524-7792
Investor Relations
Gilead Sciences, Inc.

Latest stories

Related stories

AbbVie to Invest $1.4B in North Carolina Manufacturing Plant

AbbVie has outlined plans to build a major new...

Where to Find Packaging Equipment That Meets Pharmaceutical Standards

In pharmaceutical manufacturing, you operate in an environment where...

Where to Find Leading Certification Programs for Regulatory Compliance

When you decide to buy regulatory compliance certification online,...

Trump Order Targets Faster Psychedelic Drug Reviews by FDA

The Trump administration has introduced a new executive order...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »